glp-1 fill finish cdmo A bridge between design and delivery: Exploring sterile integration for injectable product success Resilience cites GLP-1s in $225m+
Description
Those who recevied the placebo (no active drug) on average experienced 14% weight regain whilst those who continued on Tirzepatide had a further average weight loss of 5.5%
Shedding is temporary excess (both types)
2021Mar;394(3):561567
Nutrient deficiency compounds the problem Hair follicles are nutrient-hungry
But we dont know if losing that weight, after perhaps decades of being overweight or obese, causes the chronic conditions that are associated with obesity to fully go away or lessen
